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Abstract: Type 2 diabetes prevention is a major priority for healthcare services and public health.
This study aimed to evaluate how a local authority in England piloted a diabetes prevention
programme. The South Gloucestershire Diabetes Prevention (Pilot) Programme (SGDPP) comprised
a group health education course over six weeks with subsequent support provision up to six
months post-enrolment. Of the 300 patients invited onto the programme, 32% enrolled and
29% completed the full six-month programme. There was an attendance rate of 84% throughout
group sessions and at a six-month follow-up. There were significant improvements across most
measures at six months, including a 4 kg mean weight loss and a 3.45 mmol/mol mean HbA1c
reduction. Clear goals, high quality organization and personal qualities of educators were identified
as central for the programme’s success. The unit costs were similar to pilots of other healthy lifestyle
programmes. The evaluation found evidence of reduced type 2 diabetes risk markers, positive impacts
for dietary and physical activity, and potential cost-effectiveness for this format of group-based
diabetes prevention intervention. Feedback from multiple stakeholders provided insight on how to
successfully embed and scale-up delivery of diabetes prevention work. This evidence enables the
integration of learning in local service delivery and provides a basis to support development of the
national diabetes prevention programme.
Keywords: diabetes prevention; diabetes education; community programme; knowledge integration
1. Introduction
Since 1996, the number of people diagnosed with diabetes in the UK has more than doubled from
1.4 million: in 2018, there were 3.8 million people living in the UK diagnosed with diabetes and a
further estimated 1 million people living with diabetes, but as yet remain undiagnosed [1]. Around the
world, approximately 700 people a day are diagnosed with diabetes, the equivalent of one person
every two minutes; approximately 90% of these have type 2 diabetes.
Type 2 diabetes poses a significant public health and healthcare challenge, resulting in the
premature deaths of 22,000 people every year. It is a leading cause of preventable sight loss in people
of working age and is a major contributor to kidney failure, nerve damage, heart attack and stroke.
The cost of diabetes to the National Health Service (NHS) is over £1.5 million an hour, or 10% of the
NHS budget for England and Wales. In total, an estimated £14 billion is spent every year treating
diabetes and its complications, with the cost of treating complications representing a much higher
cost [2].
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Evidence suggests that the prevention of type 2 diabetes is achievable through moderate weight
loss and lifestyle changes [3], with one kilogram of weight loss being associated with a 16% reduction in
the incidence of diabetes [4]. National Institute for Care and Excellence (NICE) guidelines recommend
early detection of type 2 diabetes, as well as provision of an evidence-based intensive lifestyle-change
programme to prevent or delay the onset of type 2 diabetes for those at high risk [5–8].
Intensive lifestyle-change programmes offer ongoing tailored advice, support and encouragement
to enable people to increase their physical activity, improve diet, and gradually lose weight to reach and
maintain a healthy Body Mass Index (BMI). Such changes can, in turn, reduce the risk of developing
other long-term conditions. For example, many randomized controlled trials have shown significant
modifications in key risk factors for cardiovascular disease and certain cancers as a result of relatively
modest reductions in weight (2–3 kg) or an increase in physical activity levels (30–60 min per week of
moderate intensity) [9–13].
In 2014, the NHS published its “Five Year Forward View”, stating that a major upgrade in
prevention and public health was needed in order to sustain the NHS and the economic prosperity
of Britain. As part of this prevention strategy, the NHS Diabetes Prevention Programme (NHS DPP)
commenced rollout in England in 2016, with the aim of becoming available to the whole country by
2020. The programme, which is a joint initiative between NHS England, Public Health England (PHE)
and Diabetes UK, aims to significantly reduce the 4 million people in England otherwise expected
to have type 2 diabetes by 2025. Eligible patients receive evidence-based and personalized help to
reduce their risk of type 2 diabetes, including healthy lifestyle education, bespoke physical activity
programmes, and help to lose weight (if appropriate).
This article builds upon on steps taken by South Gloucestershire Local Authority to pilot a diabetes
prevention programme prior to the rollout of the NHS DPP in the area. It reports on the evaluation of
patient outcomes (qualitative and quantitative) immediately at the end of the pilot programme and
again at six months. It also aims to report on the process of managing and delivering the programme,
to consider lessons learned from the pilot project and how these lessons could be incorporated to
ensure the ongoing success of a diabetes prevention programme in the locality. Learning from the
pilot is intended not only to help shape the future of diabetes prevention care in South Gloucestershire,
but also to have implications for service development in this field.
The local Joint Prevention Strategy and the Long-Term Conditions Strategy have emphasized that
obesity, pre-diabetes and type 2 diabetes are priority areas for commissioners of clinical healthcare
services. In 2014, South Gloucestershire was estimated to have a population of 271,600 people,
with 25 General Practitioner (GP) practices. This presents a substantial challenge in terms of numbers
of patients at risk of developing type 2 diabetes. GP practices data across South Gloucestershire
highlighted a 6.29% rise in diabetes prevalence in the area between 2014–2015 and 2015–2016 (from
10,954 to 11,690 patients). In 2015–2016, 8.5% (511) patients in South Gloucestershire had a raised
glycated haemoglobin (HbA1c) identified during a routine health check.
Historically, diabetes education has been available in the area for those patients newly diagnosed
with the condition, but not for patients who are at ‘high risk’ of developing it. Recognizing a gap
within the service, and the rising prevalence of type 2 diabetes locally, an application was made to
Health Education South West (HESW) for funding to run a one-year pilot Diabetes Prevention Project,
from October 2015 to October 2016.
The aim of the pilot project was to identify a group of patients at risk of developing type 2 diabetes
within one GP practice and deliver a recognized diabetes prevention programme. The project also
aimed to increase staff capacity and knowledge, enabling staff to deliver diabetes prevention education
to patients in preparation for when the NHS DPP commenced in the locality.
The South Gloucestershire Diabetes Prevention (Pilot) Programme (SGDPP) was based on X-PERT
X-POD (Prevention of Diabetes), an established, manual-based programme comprising a six-week
group education course followed by telephone and email support, with meetings scheduled at three
months post-course and at six months post-enrolment. The dietary approach recommended by the
Healthcare 2019, 7, 38 3 of 10
X-POD programme is low-fat, low-carb, Mediterranean, intermittent fasting, and 500 kcal deficient [14].
The design of the programme is compliant with NICE [6] guidelines on the prevention of diabetes.
2. Materials and Methods
Two GP surgeries were chosen for the pilot. The surgeries were selected on the basis of their
capacity to offer staff and room facilities for the pilot. Following group consultation, the following
criteria for invitation to the programme were agreed: patients must be over 35 years old, and have a
previously recorded BMI of over 30 plus fit into one of the following categories: (1) family history of
diabetes; (2) previous raised HbA1c blood result (42–47 mmol inclusive); (3) history of cardiovascular
disease; (4) hypertension; (5) history of gestational diabetes or polycystic ovary syndrome; or (6) black
or minority ethnic group. These criteria were applied to the patient record at both surgeries by practice
staff, and 500 patients were identified. Of these, the first 300 listed were sent letters inviting them to
the programme. Mail was generated and sent from within the surgery in order not to breach patient
confidentiality. Letters explained to patients how to enroll in the course if they would like to do so,
with a range of times on offer.
The evaluation was structured around three areas: (1) an outcomes assessment for a sample of
participants, (2) a process evaluation of the perceptions of project implementation by participants,
project staff and wider stakeholders, and (3) a unit cost analysis.
2.1. Outcome Evaluation
This component of the evaluation focused on changes that reflect anticipated outcomes for
participants, including objectively-measured changes in weight, waist circumference and HbA1c,
and self-reported outcomes for general health, physical activity, dietary behavior, mental wellbeing,
mental ill health and social wellbeing. Study participants were all patients who met the eligibility
criteria for the diabetes prevention project. A target of at least 30 completed matched pairs of before
and after data was set.
Participants completed a baseline questionnaire at enrolment and a follow-up questionnaire at six
months. All participants were asked to provide information on their demographics, co-morbidities,
and any concurrent participation in other healthy lifestyle activities. These data were analyzed using
SPSS Statistics Version 22.0 (IBM, Armonk, NY, USA).
2.2. Process Evaluation
The process evaluation examined key aspects of the project implementation, drawing upon
theory-driven evaluation methodologies [15,16]. All participants were approached to take part in
focus groups or one-to-one interviews. An interview indicative topic guide was piloted and then used
for data collection. Audio-recorded data were transcribed and thematically analyzed using NVivo 10
(NVivo, QSR International, Melbourne, Australia). All members of the evaluation team coded and
checked the data for consistency by comparing and discussing preliminary findings.
A similar process was used to collect data from project stakeholders through interviews. Project
management meetings, the expert panel meeting, and interviews with the GP practice management
team were audio-recorded.
2.3. Unit Cost Analysis
Methodology used by Savas and Grady to evaluate an Impaired Glucose Regulation (IGR) project
in Manchester [17] was adopted to identify a range of costs linked to the SGDPP, including costs of
recruiting and enrolling participants, delivering group-based education sessions, providing follow-on
support, staff training and development, meetings, programme management and administration,
and other worker time.
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2.4. Ethical Considerations
Prospective participants in the study were provided with written information, given an
opportunity to ask questions, and asked to provide written consent. This study obtained ethical
approval through South Gloucestershire Council’s Research Governance Framework and through the
University of the West of England Research Ethics Committee (Ref: HAS/15/12/066).
3. Results
3.1. Study Sample
Three hundred eligible patients were invited onto the programme by letter. Patients responded
quickly to express interest in the groups, and initial group places filled rapidly. Some patients were
uncertain why they had been chosen, some objected to receiving a letter, while others welcomed the
opportunity to learn more about their risk. As demand exceeded expectation, further groups were
organized. In the end, a total of 95 (32%) patients enrolled, and 87 (29%) completed the course to the
six-month stage. Four of the attending partners discovered they also met the inclusion criteria, and so
enrolled and completed the course to the six-month stage. Figure 1 gives an overview of participant
recruitment and retention, while Figure 2 shows the key characteristics of the 99 participants who
started the course.
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Drop-out from the programme and evaluation was very low; only 8% of participants who started
the programme were unable to attend and provide data at the six-month follow-up meeting. All group
sessions and the six-month follow-up meeting had an attendance of at least 84%, with a 90% mean
attendance at group sessions alone. Over sixty three percent (63.6%) of participants attended all six
group sessions. Mean contact time at group sessions was 10.7 ± 2.4 h. Overall feedback on the group
sessions, provided by participants was very positive—96% scored a 9 or 10 when asked how likely
they were to recommend the course to friends or family (where ‘0’ is extremely unlikely and ‘10’ is
extremely likely); this is supported by the process evaluation findings presented in Section 3.3.
3.2. Outcomes at Six Months
Baseline and six-month follow-up data were available for 91 participants, far exceeding the
original target of 30. Table 1 shows that there were significant improvements across all measures,
except those relating to mental wellbeing and mental ill health (anxiety and depression). Almost 76%
(69) participants experienced weight loss, while 87.9% (80) had reduced HbA1c.
Table 1. Changes in means from baseline to six-month follow-up for main outcome measures.
Outcome Measure Baseline Mean(SD)
6-Month Mean
(SD)
Mean
Difference
Std. Deviation
Difference
95% CI of
Difference
Weight (kg) 93.50 (16.38) 89.45 (16.28) −4.04 **,2 4.62 −5.01, −3.08
BMI (kg/m2) 33.81 (5.95) 32.38 (6.10) −1.43 ** 1.62 −1.77, −1.09
Waist circumference (cm) 107.37 (12.22) 102.05 (12.50) −5.32 ** 5.03 −6.37, −4.27
HbA1c (mmol/mol) 42.24 (5.26) 38.79 (3.46) −3.45 ** 4.07 −4.30, −2.60
Proportion meeting recommended
physical activity guidelines 1 0.16 (0.37) 0.30 (0.46) 0.13 * 0.48 0.03, 0.23
Mean no. of min/week of MVPA 189.43 (275.26) 421.66 (498.15) 232.23 ** 488.15 130.57, 333.89
Overall self-reported dietary behavior 49.68 (7.38) 47.24 (7.46) −2.45 ** 5.93 −3.68, −1.21
Mental wellbeing (max score = 35) 3 27.59 (5.04) 27.64 (5.02) 0.04 3.61 −0.71, 0.80
Anxiety (max score = 28) 10.00 (3.91) 9.74 (3.41) −0.26 2.89 −0.86, 0.34
Depression (max score = 36) 12.87 (4.93) 12.49 (4.42) −0.37 3.19 −1.04, 0.29
* p < 0.01; ** p ≤ 0.001. 1 At least 150 min/week of moderate-to-vigorous physical activity (MVPA). 2 Equivalent to
4.3% mean weight loss. 3 max = maximum.
Further analysis found that:
• Males lost more weight than females:Males:
Males: M = −5.85 kg ± 4.79 kg; Females: M = −2.97 kg ± 4.19 kg; t (89) = −3.00, p = 0.003.
• Participants living in more deprived areas lost more weight than those in less deprived areas:
Higher Index of Multiple Deprivation (IMD) decile: M = −5.58 kg ± 5.45 kg;
Lower IMD decile: M = −2.95 kg ± 3.58 kg; t (59.3) = −2.60, p = 0.012.
Associations between weight loss and age category, employment status and educational level
were either absent or could not be determined due to small sample sizes. Additional investigations on
weight change at six months were done for the 86 participants who were overweight or obese (BMI ≥
25 kg/m2):
• 60.5% (52) achieved 2 kg weight loss, pre-set as the target for a minimum clinically important
difference (MCID).
• Weight loss thresholds widely adopted in weight management programmes are at least 3%, 5% or
10%—the proportion of participants who achieved these thresholds were 52.3% (45), 40.7% (35)
and 12.8% (11), respectively.
Results from stepwise multiple regression found that gender, followed by area deprivation,
were predictors of weight change at six months (p < 0.01). Three other factors—contact time at
group sessions, comorbidities, and prior and/or concurrent engagement with other healthy lifestyle
activities—were not predictors of weight change.
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3.3. Process Evaluation Findings: Participants
Data were collected from 67 participants through 14 focus groups, five one-to-one interviews
and one written feedback. They suggest that aspects of the project that were vital to its success
were organization, clarity of goals and personal qualities of the delivery team. Positive elements of
participant feedback are summarized in Table 2. A majority of participants completed the programme
and attended focus groups. This suggested that the intervention was well-received.
Table 2. Summary of positive elements of qualitative participant feedback in focus groups.
General Aspects of the
Programme
Experience of Sessions
and Educators
Impact on Individual Other Positive Elements
• Overall clarity of
key messages
• Clear format and
organization of
the programme
• ‘Soft’ and ‘hard’ skills
of group educators
• Personalized support
on specific matters
• ‘Professional’
handling of
sensitive issues
• Peer support and
opportunities
for participation
• Personal relevance and
importance of
the programme
• Perceived influence of
the programme on
knowledge, skills,
attitudes, motivations to
change and confidence to
manage risk
• Shared learning beyond
the group: family, friends
and acquaintances
• Diabetes prevention is a
very important issue to
disseminate locally, not just
with at-risk groups, but
with the wider public
(including children)
and professionals
• Some participants felt
motivated to help
professionals in this work
Suggestions for Programme Development and Rollout
Participants recommended that project staff be ready to respond to requests for more information,
following mail-outs of the initial letter of invitation. This was seen as a crucial moment for
patient engagement to address any feelings of surprise or shock. The programme itself would
benefit from revisions to make some aspects of the education more comprehensible, particularly
the pathophysiology of diabetes and dietary advice. However, participants recognized that this was
challenging given the nature of the subject matter. Some participants suggested more emphasis on
goals and strategies for increasing physical activity levels. Opportunities for inter-group networking
and for maintaining contact after the programme were recommended to promote sustainability of
behavior change and knowledge sharing as part of wider community initiatives.
3.4. Process Evaluation Findings: Staff and Wider Stakeholders
Three delivery team members, two trained patient representatives and two GP surgery staff
participated in interviews and provided written feedback. An expert panel of ten practitioners
(external to the programme) representing local authority, GP practices, local Clinical Commissioning
Groups, and community and voluntary sector agencies, provided feedback on preliminary evaluation.
Staff and wider stakeholders perceived that the pilot project performed very strongly. Take-up
(at 29%) and retention (at 92%) were considerably higher than the steering group anticipated; based on
work in other areas, the group anticipated recruiting no more than 20% of invitees and retaining
under 80% of course participants at six months. However, the GP surgery catchment areas do not
include areas of high relative deprivation in contrast to many GP practices in the local region. Staff and
stakeholders felt recruitment and retention would be more challenging if the project had been delivered
in areas of higher deprivation.
The delivery team had no prior experience of running a diabetes prevention project. However,
they had an extensive track record in running similar lifestyle education initiatives to draw upon
and combined this with expert input from partners, such as the Diabetic Specialist Nursing Service.
The project benefited from a well-briefed, engaged and supportive GP practice team that had an
essential role in identifying eligible patients and managing the initial mail-out. Practice staff did not
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perceive any undue burdens on work resulting from the project. Considerable effort was put in by
the delivery team to build relationships with participants both during and after the group stage of
the project. Staff appreciated the trailblazing nature of the pilot for the locality and recognized the
potential benefits of involving participants in the programme’s development.
3.5. Unit Cost Analysis
The NHS DPP intervention costs are estimated to be £270 per person over an 18-month period;
these are weighted in the first six months and exclude expenditure on case-finding and referrals
to the programme [18]. For the SGDPP, the estimated cost per person was £167, including project
set-up, delivery, administration and management over six months. Sensitivity analysis found the
cost per person ranged from £107 to £495, with higher costs including X-PERT training, equipment
and evaluation.
4. Discussion
This evaluation of the SGDPP has identified some highly promising aspects of the pilot
programme. Outcome data show that the programme was associated with positive changes in weight,
HbA1c, diet and physical activity measures across a wide distribution of demographic characteristics.
The mean weight loss of 4.3% at six months was comparable to the 4% weight loss reported from
the systematic review and meta-analysis of twenty-eight US diabetes prevention translation studies,
albeit the latter was achieved at 12 months [19]. Given that the landmark US Diabetes Prevention
Program trial established weight loss as the single most important factor in reducing diabetes incidence
(16% reduction in diabetes incidence for every kilogram of weight loss [20]), the 4.04 kg weight loss
achieved in the community-based SGDPP is a key result.
The SGDPP exceeded its initial targets for recruitment, delivery and retention. Clear goals,
high quality organization, and personal qualities of the delivery team were identified as important
features supporting the strong programme uptake and participant retention, satisfaction with the group
elements, and participants’ commitment to achieving goals that directly reduce their risk of diabetes.
Feedback and patterns of retention suggest that the programme was generally very well-received,
not only by participants but by the GP surgery team and associated health and community services.
Staff at the main participating GP surgery anticipated that the initiative could be readily adopted in
similar settings provided there were similar resources, project staff skills and preparatory activities
with the surgery.
There is some evidence supporting the efficiency and cost-effectiveness of diabetes education
in a group setting compared with an individual setting [21]. The NHS DPP programme guidance
emphasizes that the retention and adherence to NICE programme delivery guidance are critical factors
in achieving cost-effectiveness. The start-up unit costs of the SGDPP appear to be similar to other
pilot intensive preventative lifestyle programmes and are anticipated to reduce over time as delivery
becomes embedded at the local level.
The SGDPP and NHS DPP follow a screen and treat approach, in which a subpopulation is
identified as ‘high-risk’ and offered individual intervention. This is one of the two approaches to
preventing type 2 diabetes, the other being the public health approach of changing behavior in a
whole population at risk through policies on environmental moderators (sociocultural influences,
socioeconomic influences, transport, green spaces) [22]. It is important to understand and evaluate
complex interventions such as the SGDPP, and then be able to systematically embed evaluation
findings into routine practice to improve the quality and effectiveness of health services and care [23].
Nevertheless, research suggests that the screen and treat approach needs to be complemented by
population-wide public health approaches to have substantial impact on the worsening of type
2 diabetes [22].
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4.1. SGDPP Areas for Development
Participants and stakeholders identified several areas of the programme that require further
development. Firstly, there is the challenge of anticipating and appropriately addressing any negative
reactions or queries to the initial GP letter of invitation. Contents of the programme may need to be
revised to reduce the complexity of the diabetes pathophysiology education and dietary advice, and to
have more emphasis on physical activity and behavior change techniques. The programme could
have included greater focus on smoking cessation, blood pressure and lipid management. There was
scope to refine the role of the expert patient and any co-facilitators, especially with regards to physical
activity. It is also important to consider the longer-term development of the programme in terms of
networking, support and community-based activities. Since the setting for the pilot was not an area of
high social deprivation or high racial-ethnic diversity, the programme may need further adaptation or
revision if delivered in areas with a different demographic profile.
4.2. Strengths and Limitations of the Evaluation
The SGDPP evaluation was done on a small scale, and only tracked participants’ progress up to six
months and overall programme delivery over 12 months. Due to limited resources for the evaluation,
multimode approaches or follow-up phone calls could not be implemented alongside the invitation
letters to increase the response rate. Limited resources also meant that a before-and-after study
design was employed, therefore precluding a comparison between participants’ outcomes and normal
care. However, this study design allowed for tests of association between baseline and follow-up
characteristics and enabled the role of demographic and programme-linked variables in predicting
retention to be assessed. The evaluation might have included longer-term follow-up measurements,
particularly of weight and HbA1c. The process evaluation component was essential in helping to
develop an account of how and why the programme may be contributing towards its stated goals
and of the context within which the programme was implemented. Nevertheless, it is important to
be aware that the study provides limited insight into the outcomes of the programme if it was to be
scaled-up and replicated in other settings.
5. Conclusions
The success of pilot projects such as the SGDPP and its evaluation rely on close partnerships with
all stakeholders, including local authority public health, clinical commissioners, primary care and the
voluntary sector. The SGDPP evaluation provides evidence of reduced risk markers for type 2 diabetes,
positive impacts for dietary and physical activity, and potential cost-effectiveness for this format
of group-based diabetes prevention intervention. Recruitment, retention and six-month outcomes
surpassed initial expectations. Feedback from participants, staff and stakeholders was positive, and has
provided insight on how to successfully embed and scale-up the delivery of diabetes prevention work.
This evidence enables the integration of learning into a local service delivery and provides a basis to
support development and scale-up of the NHS DPP.
Author Contributions: Conceptualization, M.J.; Formal analysis, M.S.Y.K. and M.J.; Investigation, M.S.Y.K.,
L.B. and M.J.; Methodology, M.S.Y.K. and M.J.; Project administration, L.B.; Supervision, M.J.; Validation, M.J.;
Visualization, M.S.Y.K.; Writing—original draft, M.S.Y.K. and L.B.; Writing—review & editing, C.C., S.B. and M.J.
Funding: This research was funded by Health Education South West Membership Council Innovation Fund,
grant number Inn-2015-24.
Acknowledgments: We would like to thank all participants and stakeholders who supported this work.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to
publish the results.
Healthcare 2019, 7, 38 9 of 10
References
1. Diabetes Prevalence 2018. Available online: https://www.diabetes.org.uk/professionals/position-
statements-reports/statistics/diabetes-prevalence-2018 (accessed on 25 February 2019).
2. Kanavos, P.; Van Den Aardweg, S.; Schurer, W. Diabetes Expenditure, Burden of Disease and Management in 5
EU Countries; London School of Economics: London, UK, January 2012.
3. Lindström, J.; Ilanne-Parikka, P.; Peltonen, M.; Aunola, S.; Eriksson, J.G.; Hemiö, K.; Hämäläinen, H.;
Härkönen, P.; Keinänen-Kiukaanniemi, S.; Laakso, M.; et al. Sustained reduction in the incidence of type
2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368,
1673–1679. [CrossRef]
4. Knowler, W.C.; Barrett-Connor, E.; Fowler, S.E.; Hamman, R.F.; Lachin, J.M.; Walker, E.A.; Nathan, D.M.
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEJM 2002, 346,
393–403. [PubMed]
5. Type 2 Diabetes Prevention: Population and Community-Level Interventions. In Public Health Guideline
PH35; Available online: https://www.nice.org.uk/guidance/ph35 (accessed on 4 September 2018).
6. Type 2 Diabetes: Prevention in People at High Risk. In Public Health Guideline PH38; Available online:
https://www.nice.org.uk/guidance/ph38 (accessed on 4 September 2018).
7. Type 2 Diabetes in Adults: Management. In NICE Guideline NG28; Available online: https://www.nice.org.
uk/guidance/ng28 (accessed on 4 September 2018).
8. Obesity in Adults: Prevention and Lifestyle Weight Management Programmes. In Quality Standard QS111;
Available online: https://www.nice.org.uk/guidance/qs111 (accessed on 4 September 2018).
9. Aucott, L.; Poobalan, A.; Smith, W.C.S.; Avenell, A.; Jung, R.; Broom, J.; Grant, A.M. Weight loss in obese
diabetic and non-diabetic individuals and long-term diabetes outcomes: Systematic review. Diabetes Obes.
Metab. 2004, 6, 85–94. [CrossRef] [PubMed]
10. Avenell, A.; Brown, T.J.; McGee, M.A.; Campbell, M.K.; Grant, A.M.; Broom, J.; Jung, R.T.; Smith, W.C. What
interventions should we add to weight reducing diets in adults with obesity? A systematic review. J. Hum.
Nutr. Diet. 2004, 17, 293–316. [CrossRef] [PubMed]
11. Bo, S.; Ciccone, G.; Baldi, C.; Benini, L.; Dusio, F.; Forastiere, G.; Lucia, C.; Nuti, C.; Durazzo, M.; Cassader, M.;
et al. Effectiveness of a lifestyle intervention on metabolic syndrome: Randomised controlled trial. J. Gen.
Intern. Med. 2007, 22, 1695–1703. [CrossRef] [PubMed]
12. Esposito, K.; Marfella, R.; Ciotola, M.; Di Palo, C.; Giugliano, F.; Giugliano, G.; D’Armiento, M.; D’Andrea, F.;
Giugliano, D. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular
inflammation in the metabolic syndrome: A randomized trial. JAMA 2004, 292, 1440–1446. [CrossRef]
[PubMed]
13. Laaksonen, D.E.; Lindström, J.; Lakka, T.A.; Eriksson, J.G.; Niskanen, L.; Wikström, K.; Aunola, S.;
Keinänen-Kiukaanniemi, S.; Laakso, M.; Valle, T.T.; et al. Physical activity in the prevention of type 2
diabetes the Finnish Diabetes Prevention Study. Diabetes 2005, 54, 158–165. [CrossRef] [PubMed]
14. X-PERT Prevention and Management Summary. Available online: https://www.xperthealth.org.uk/
Programmes/X-POD-Overview (accessed on 25 February 2019).
15. Pawson, R.; Tilley, N. Realistic Evaluation; Sage: London, UK, 1997.
16. Connell, J.P.; Kubisch, A.C. Applying a theory of change approach to the evaluation of comprehensive
community initiatives: Progress, prospects, and problems. In New Approaches to Evaluating Community
Initiatives: Theory, Measurement, and Analysis; Fulbright-Anderson, K., Kubisch, A.C., Connell, J.P., Eds.;
Aspen Institute: Washington, DC, USA, 1998; Volume 2, pp. 15–44.
17. Savas, L.; Grady, K. The IGR Care Call Project Evaluation Report; University of Manchester: Manchester,
UK, 2013.
18. Local Health and Care Planning: Menu of Preventative Interventions. Available online: https://bit.ly/
2TSmx31 (accessed on 4 September 2018).
19. Ali, M.K.; Echouffo-Tcheugui, J.B.; Williamson, D.F. How effective were lifestyle interventions in real-world
settings that were modelled on the Diabetes Prevention Program? Health Affairs 2012, 31, 67–75. [CrossRef]
[PubMed]
Healthcare 2019, 7, 38 10 of 10
20. Hamman, R.F.; Wing, R.R.; Edelstein, S.L.; Lachin, J.M.; Bray, G.A.; Delahanty, L.; Hoskin, M.; Kriska, A.M.;
Mayer-Davis, E.J.; Pi-Sunyer, X.; et al. Effect of weight loss with lifestyle intervention on risk of diabetes.
Diabetes Care 2006, 29, 2102–2107. [CrossRef] [PubMed]
21. Rickheim, P.L.; Weaver, T.W.; Flader, J.L.; Kendall, D.M. Assessment of group versus individual diabetes
education: A randomized study. Diabetes Care 2002, 25, 269–274. [CrossRef] [PubMed]
22. Barry, E.; Roberts, S.; Oke, J.; Vijayaraghavan, S.; Normansell, R.; Greenhalgh, T. Efficacy and effectiveness of
screen and treat policies in prevention of type 2 diabetes: Systematic review and meta-analysis of screening
tests and interventions. BMJ 2017, 356, i6538. [CrossRef] [PubMed]
23. Nilsen, P. Making sense of implementation theories, models and frameworks. Implement. Sci. 2015, 10, 53.
[CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
